Opaleye Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-566,700
| Closed | -$6.21M | – | 53 |
|
|
2023
Q2 | $6.21M | Buy |
+566,700
| New | +$6.21M | 1.48% | 18 |
|
|
2021
Q4 | – | Sell |
-115,015
| Closed | -$420K | – | 50 |
|
|
2021
Q3 | $420K | Buy |
+115,015
| New | +$420K | 0.08% | 47 |
|
|
2019
Q4 | – | Sell |
-140,000
| Closed | -$717K | – | 53 |
|
|
2019
Q3 | $717K | Buy |
+140,000
| New | +$717K | 0.26% | 45 |
|
|
2019
Q2 | – | Sell |
-550,000
| Closed | -$7.3M | – | 55 |
|
|
2019
Q1 | $7.3M | Sell |
550,000
-175,000
| -24% | -$2.32M | 2.02% | 21 |
|
|
2018
Q4 | $5.71M | Buy |
725,000
+26,900
| +4% | +$212K | 2.13% | 17 |
|
|
2018
Q3 | $7.74M | Buy |
698,100
+600
| +0.1% | +$6.65K | 1.97% | 19 |
|
|
2018
Q2 | $9.36M | Buy |
697,500
+32,500
| +5% | +$436K | 2.42% | 12 |
|
|
2018
Q1 | $8.64M | Hold |
665,000
| – | – | 2.47% | 11 |
|
|
2017
Q4 | $6.12M | Hold |
665,000
| – | – | 1.96% | 16 |
|
|
2017
Q3 | $5.36M | Buy |
+665,000
| New | +$5.36M | 1.89% | 18 |
|